Dhouafli Z, Leri M, Bucciantini M, Stefani M, Gadhoumi H, Mahjoub B, Ben Jannet H, Guillard J, Tounsi MS, Ksouri R, Hayouni EA. A new purified Lawsoniaside remodels amyloid-β42 fibrillation into a less toxic and non-amyloidogenic pathway. Int J Biol Macromol. 2018 Jul 15;114:830-835. Epub 2018 Apr 4 PubMed.
Recommends
Please login to recommend the paper.
Comments
No Available Comments
Make a Comment
To make a comment you must login or register.